In the past 10 years the number of antipsychotics prescribed to children with psychiatric disorders have skyrocketed. Despite this rapid growth, most medications have been inadequately studied in children for safety or efficacy and many have serious adverse health. Measures are needed to ensure that the health and safety of children are being protected, and debates have emerged over whether or not clinical trials in this population should be conducted. This edited volume reviews the latest findings for the safety and efficacy of antipsychotic use in children and examines tensions that are created by off-label use, both in clinical psychiatric practice and research.
Offers coverage of efficacy, prevalence, and adverse impacts of the use of antipsychotics in children
Explores ethics challenges of clinical research in this patient population
Serves as a platform for future discussions designed to increase the safety of children taking antispychotics
Edited work with chapters authored by leading neuroethicists in the field around the globe - the broadest, most expert coverage available"
Or split into 4x interest-free payments of 25% on orders over R50
Learn more
In the past 10 years the number of antipsychotics prescribed to children with psychiatric disorders have skyrocketed. Despite this rapid growth, most medications have been inadequately studied in children for safety or efficacy and many have serious adverse health. Measures are needed to ensure that the health and safety of children are being protected, and debates have emerged over whether or not clinical trials in this population should be conducted. This edited volume reviews the latest findings for the safety and efficacy of antipsychotic use in children and examines tensions that are created by off-label use, both in clinical psychiatric practice and research.
Offers coverage of efficacy, prevalence, and adverse impacts of the use of antipsychotics in children
Explores ethics challenges of clinical research in this patient population
Serves as a platform for future discussions designed to increase the safety of children taking antispychotics
Edited work with chapters authored by leading neuroethicists in the field around the globe - the broadest, most expert coverage available"
Imprint | Academic Press Inc |
Country of origin | United States |
Release date | April 2015 |
Availability | Expected to ship within 12 - 17 working days |
First published | 2015 |
Editors | Nina Di Pietro, Judy Illes |
Dimensions | 229 x 152 x 16mm (L x W x T) |
Format | Hardcover |
Pages | 205 |
ISBN-13 | 978-0-12-800016-8 |
Barcode | 9780128000168 |
Categories | |
LSN | 0-12-800016-3 |